on 31 Aug 2021
Last Applicant/ Owned by
BioBay, Suzhou Industrial Park, Suzhou
CN
Serial Number
79278137 filed on 28th Oct 2019
Registration Number
6465606 registered on 31st Aug 2021
Correspondent Address
Eric Lamb
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficie Read More
Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicinal preparations for the mouth in the form of tablets or compressed tablets for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicines for human purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; biochemical medical drug for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical preparations for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; drugs for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; active pharmaceutical ingredients for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders
No 79278137
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
27th Feb 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
07th Feb 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
07th Feb 2022 | FINAL DISPOSITION PROCESSED |
30th Nov 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
31st Aug 2021 | REGISTERED-PRINCIPAL REGISTER |
24th Jul 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
07th Jul 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
07th Jul 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
15th Jun 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
15th Jun 2021 | PUBLISHED FOR OPPOSITION |